Gene Bridges granted Patents in Japan and Mexico for Recombineering Technology
Gary Stevens, CEO of Gene Bridges GmbH, commented: 'Japan is a very important and growing market for us and this patent marks an important step in the international recognition of Red/ET while the Mexican patent strengthens our already strong position in North America.These important milestones in two new markets demonstrates that recombineering is the technology of choice in DNA engineering and is used worldwide in industry and academia.' Gene Bridges is represented in Japan by the company Funakoshi.
Red/ET is a method for DNA engineering. Recombineering with Red/ET allows cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs or the E.coli chromosome, according to the company.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.